BIO-RAD LABORATORIES, INC. (BIO) Form 10-Q Quarterly Reports
BIO-RAD LABORATORIES, INC. (BIO) is a publicly traded company on the NYSE, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BIO
CIK: 12208
Exchange: NYSE
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJody Mortimore
Audit LocationSanta Clara, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001924980-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002022345-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001993147-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002024911-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001453524-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002019843-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002081681-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001396867-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0000940805-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0002022345-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001924980-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0000940805-26-000002 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0000012208-26-000048 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-31 | 8-K | 0000012208-26-000046 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-25 | FORM 4 | 0002024911-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-05-28 | — | 144 Filing | 0001957225-26-000001 | View SEC Doc Filr Page |
| SD | 2026-05-13 | — | SD | 0000012208-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | FORM 4 | 0002024911-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-05-11 | — | 144 Filing | 0001950047-26-004354 | View SEC Doc Filr Page |
| S-8 | 2026-04-30 | — | S-8 | 0000012208-26-000037 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0000012208-26-000035 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0000012208-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-04-28 | 2026-04-24 | FORM 4 | 0001396867-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-28 | 2026-04-24 | FORM 4 | 0002019843-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-21 | 8-K | 0000012208-26-000024 | View SEC Doc Filr Page |